Originales
Coste-efectividad de la adición de acarbosa al tratamiento de pacientes con diabetes tipo 2 en España
Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain
Carme Piñola,
, Stephane Rozeb, William Valentineb, Thomas Eversc
Corresponding author
carmen.pinol.cp@bayer.es
Correspondencia: Carme Piñol. Unidad de Farmacoeconomía y Relaciones Institucionales. Departamento de Investigación y Desarrollo. Química Farmacéutica Bayer, S. A. Pau Claris, 196. 08037 Barcelona. España.
Correspondencia: Carme Piñol. Unidad de Farmacoeconomía y Relaciones Institucionales. Departamento de Investigación y Desarrollo. Química Farmacéutica Bayer, S. A. Pau Claris, 196. 08037 Barcelona. España.
Read
1231
Timeswas read the article
478
Total PDF
753
Total HTML
Article information
ISSN: 02139111Original language: Spanish
DOI:10.1157/13101034
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 40 | 14 | 54 |
| 2024 November | 58 | 38 | 96 |
| 2024 October | 58 | 30 | 88 |
| 2024 September | 44 | 21 | 65 |
| 2024 August | 62 | 31 | 93 |
| 2024 July | 41 | 19 | 60 |
| 2024 June | 35 | 31 | 66 |
| 2024 May | 43 | 60 | 103 |
| 2024 April | 30 | 17 | 47 |
| 2024 March | 32 | 18 | 50 |
| 2024 February | 38 | 38 | 76 |
| 2024 January | 26 | 24 | 50 |
| 2023 December | 31 | 13 | 44 |
| 2023 November | 34 | 25 | 59 |
| 2023 October | 38 | 18 | 56 |
| 2023 September | 33 | 20 | 53 |
| 2023 August | 25 | 17 | 42 |
| 2023 July | 37 | 22 | 59 |
| 2023 June | 33 | 13 | 46 |
| 2023 May | 15 | 9 | 24 |
Show all
